Abera Bioscience AB
Developing next-generation nasal vaccines using modular OMV platform technology.
Overview
- Unknown
- Employees
- Unknown
- Revenue
- 2012
- Founded
Key Decision Makers
Maria Alriksson
CEO
Mats Lundgren
CSO
Anders Ericsson
Executive Chairman of the Board
Joen Luirink
CTO, Co-Founder
+3 more contacts in Funnelfeedr
Description
Abera Bioscience AB is a Swedish biotechnology company specializing in the development of next-generation vaccines. They utilize a proprietary, modular Outer Membrane Vesicle (OMV) platform technology. This platform allows for rapid design and cost-effective production of vaccines that induce robust...